Otsuka encourages caregivers to talk to physicians about agitation in Alzheimer's in new campaign.
July 26, 2023 03:34 PM EDTUpdated July 27, 01:41 PM
Pharma
Marketing

Ot­su­ka, Lund­beck­'s new cam­paign spot­lights ag­i­ta­tion symp­toms in Alzheimer’s dis­ease

Beth Snyder Bulik

Senior Editor

About half of old­er peo­ple liv­ing with Alzheimer’s dis­ease will de­vel­op ag­i­ta­tion, man­i­fest­ed in ways such as ver­bal or phys­i­cal ag­gres­sion or rest­less­ness. But it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times